Description
TTP 22 is an inhibitor of casein kinase 2 (CK2) that may alter cell survival, cell cycle control, DNA repair, and Wnt signaling; it is likely in development for potential anticancer activity.
TTP 22 is an inhibitor of casein kinase 2 (CK2) that may alter cell survival, cell cycle control, DNA repair, and Wnt signaling; it is likely in development for potential anticancer activity.
| Cas No. | 329907-28-0 |
|---|---|
| Purity | ≥98% |
| Formula | C16H14N2O2S2 |
| Formula Wt. | 330.42 |
| IUPAC Name | 3-{[5-(4-Methylphenyl)thieno[2,3-d]pyrimidin-4-yl]sulfanyl}propanoic acid |
| Solubility | ethanol 20mM DMSO 100mM |
| Store Temp | -20°C |
|---|---|
| Ship Temp | Ambient |
| MSDS | |
|---|---|
| Info Sheet |
Golub AG, Bdzhola VG, Briukhovetska NV, et al. Synthesis and biological evaluation of substituted (thieno[2,3-d]pyrimidin-4-ylthio)carboxylic acids as inhibitors of human protein kinase CK2. Eur J Med Chem. 2011 Mar;46(3):870-6. PMID: 21276643.
Gao Y, Wang HY. Casein kinase 2 Is activated and essential for Wnt/beta-catenin signaling. J Biol Chem. 2006 Jul 7;281(27):18394-400. PMID: 16672224.
Fluoroquinolone; topoisomerase IV and bacterial...
Fluoroquinolone; topoisomerase IV and bacterial...
Steroid lactone produced by Withania somnifera;...
Cyclic peptide mycotoxin produced by Alternaria...
JAK2 inhibitor.
TxA2 synthase inhibitor.
Cationic lipid polypeptide, mixture of polymyxi...
Alters membrane permeability and Ca2+ signaling...
Indoleamine 2,3-dioxygenase inhibitor.
RXR agonist.
Endogenous quaternary ammonium, required for fa...
ALK and Ros1 inhibitor, Trk antagonist.
DHF reductase inhibitor.
MDM2 inhibitor.
Nrf2-Keap1-ARE complex activator.
Ras inhibitor.
PAK4 inhibitor.
ERK1/2 inhibitor.
Endogenous pterin coenzyme required for release...
VEGFR inhibitor.